Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Appointed director
Quarterly results
Diffusion Pharmaceuticals Inc. (DFFN) Create: Alert

All | News | Filings
Date FiledTypeDescription
09/04/2020 8-K Appointed a new director
Docs: "Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors Romanian Regulatory Approval Received to Begin Phase 1b COVID-19 Clinical Trial CHARLOTTESVILLE, Va. – Diffusion Pharmaceuticals Inc. , a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, today announced the appointment of Jane H. Hollingsworth to its board of directors, effective immediately. Ms. Hollingsworth’s appointment expands the board to seven directors. In addition to serving as a director, she will join the Nominating & Corporate Governance, Compensation and Audit Committees of the Board. Ms. Hollingsworth brings to Diffusion more than 25 years of experience founding and lea..."
07/06/2017 8-K Form 8-K - Current report
08/16/2016 8-K Appointed a new director
03/14/2008 8-K Appointed a new director
Docs: "Agreement and Plan of Merger",
"Amendment to Agreement and Plan of Merger",
"Employment Agreement between Pro Sports Entertainment, Inc. and Paul Feller"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy